OSCR

OSCAR HEALTH INVESTORS: July 11, 2022 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

Retrieved on: 
Tuesday, May 17, 2022 - 2:00pm

A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.

Key Points: 
  • A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.
  • You may retain Lieff Cabraser, or other attorneys, as your counsel in the action.
  • In March 2021, Oscar Health completed its IPO, selling 36 million shares of Class A common stock at $39 per share, for proceeds of approximately $1.3 billion.
  • The National Law Journal has recognized Lieff Cabraser as one of the nations top plaintiffs law firms for fourteen years.

Shareholder Alert: Robbins LLP informs Shareholders of Class Action Against Oscar Health, Inc.  

Retrieved on: 
Tuesday, May 17, 2022 - 8:21am

The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Oscar Health, Inc. (NYSE: OSCR) securities pursuant to the Company's March 2021 initial public offering ("IPO").

Key Points: 
  • The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Oscar Health, Inc. (NYSE: OSCR) securities pursuant to the Company's March 2021 initial public offering ("IPO").
  • Oscar Health is a health insurance company that claims to be the first company "built around a full stack technology platform."
  • If you would like more information about Oscar Health, Inc.'s misconduct, click here .
  • Specifically, it omitted to state that Oscar was experiencing growing COVID-19 testing and treatment costs as well as growing net COVID-19 costs.

OSCAR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Oscar Health, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, May 17, 2022 - 2:00am

Investors have until July 12, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until July 12, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • In March 2021, Oscar conducted its IPO, selling 36,391,946 shares of Class A common stock at a price of $39.00 per share.
  • The Company also disclosed that its net loss for the quarter was $73.1 million, an increase of $32.1 million year-over-year.
  • Then, on November 10, 2021, Oscar disclosed that its third quarter 2021 MLR increased 920 basis points year-over-year, to 99.7%.

EQUITY ALERT: Rosen Law Firm Encourages Oscar Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – OSCR

Retrieved on: 
Monday, May 16, 2022 - 7:37pm

WHAT TO DO NEXT: To join the Oscar class action, go to https://rosenlegal.com/submit-form/?case_id=6200 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Oscar class action, go to https://rosenlegal.com/submit-form/?case_id=6200 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Oscar Health, Inc. (OSCR) Investors

Retrieved on: 
Monday, May 16, 2022 - 5:05pm

Oscar investors have until July 11, 2022, to file a lead plaintiff motion.

Key Points: 
  • Oscar investors have until July 11, 2022, to file a lead plaintiff motion.
  • In March 2021, Oscar conducted its IPO, selling 36,391,946 shares of Class A common stock at a price of $39.00 per share.
  • On November 10, 2021, Oscar disclosed that its third quarter 2021 medical loss ratio (MLR) increased 920 basis points year-over-year, to 99.7%.
  • The Company also disclosed that its net loss for the quarter was $212.7 million, an increase of $133.6 million year-over-year.

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Oscar Health, Inc. with Losses of $100,000 to Contact the Firm

Retrieved on: 
Monday, May 16, 2022 - 2:54pm

The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR ) for violations of the federal securities laws.

Key Points: 
  • The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR ) for violations of the federal securities laws.
  • If you are a shareholder who suffered a loss, click here to participate .
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

OSCAR HEALTH, INC. (NYSE: OSCR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Oscar Health, Inc. (NYSE: OSCR)

Retrieved on: 
Saturday, May 14, 2022 - 6:30am

NEW YORK, May 14, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or otherwise acquired the common stock of Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR) pursuant to and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s March 2021 initial public offering (“IPO” or the “Offering”). The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1933.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1933.
  • In March 2021, Oscar conducted its IPO, selling 36,391,946 shares of Class A common stock at a price of $39.00 per share.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Oscar Health, Inc. Investors: Contact the Portnoy Law Firm to Recover Losses

Retrieved on: 
Saturday, May 14, 2022 - 12:31am

LOS ANGELES, May 13, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Oscar Health, Inc. Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR) investors that a class action filed on behalf of investors. Cano Health investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.

Key Points: 
  • LOS ANGELES, May 13, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Oscar Health, Inc. Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR) investors that a class action filed on behalf of investors.
  • Cano Health investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors options for pursuing claims to recover their losses.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.

INVESTOR ALERT: Oscar Health, Inc. Investors with Substantial Losses Have Opportunity to Lead the Oscar Health Class Action Lawsuit - OSCR

Retrieved on: 
Saturday, May 14, 2022 - 12:21am

Lead plaintiff motions for the Oscar Health class action lawsuit must be filed with the court no later than July 11, 2022.

Key Points: 
  • Lead plaintiff motions for the Oscar Health class action lawsuit must be filed with the court no later than July 11, 2022.
  • A lead plaintiff acts on behalf of all other class members in directing the Oscar Health class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the Oscar Health class action lawsuit.
  • An investors ability to share in any potential future recovery of the Oscar Health class action lawsuit is not dependent upon serving as lead plaintiff.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Oscar Health, Inc. with Losses of $100,000 to Contact the Firm

Retrieved on: 
Friday, May 13, 2022 - 8:41pm

The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR ) for violations of the federal securities laws.

Key Points: 
  • The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR ) for violations of the federal securities laws.
  • If you are a shareholder who suffered a loss, click here to participate .
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.